Physician profile
Daniel C Eckert
NPI 1275742728
$10,555.30
in general payments reported to CMS, 2019-2025
37 companies · $1,842 in 2025
The $1,842 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,987 · 2020: $322 · 2021: $2,557 · 2022: $1,456 · 2023: $1,462 · 2024: $929 · 2025: $1,842.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,984 · Travel and Lodging: $1,249.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,984.06 |
| Travel and Lodging | $1,248.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $5,625.90 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Abbott Laboratories | $1,555.03 | 2019-2025 | Triclip, Amplatzer Talisman, Mitraclip |
| Amgen INC. | $700.76 | 2019-2023 | Repatha |
| Abiomed | $548.03 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $343.76 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $212.41 | 2019-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $185.31 | 2019-2022 | |
| Terumo Medical Corporation | $171.42 | 2019-2024 | |
| Atricure, INC. | $164.73 | 2023-2024 | |
| Boston Scientific Corporation | $139.64 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $80.82 | 2019-2021 | |
| Pfizer INC. | $80.25 | 2019 | |
| Braemar Manufacturing, LLC | $68.53 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $61.08 | 2019-2020 | |
| Vifor Pharma, INC. | $58.80 | 2019-2020 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $47.47 | 2024 | Manta |
| Cardiovascular Systems INC. | $44.15 | 2019-2021 | |
| Actelion Pharmaceuticals US, INC. | $43.96 | 2019 | |
| Vital Connect, INC | $39.84 | 2024 | Vitalpatch Rtm |
| Gilead Sciences, INC. | $35.45 | 2019 | |
| Stryker Corporation | $34.07 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Avinger INC. | $33.36 | 2021 | |
| Amarin Pharma, INC. | $29.90 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $26.93 | 2019-2025 | Camzyos |
| Bayer Healthcare Pharmaceuticals INC. | $25.32 | 2019-2021 | |
| Inari Medical, INC. | $24.90 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Regeneron Healthcare Solutions, INC. | $23.78 | 2019 | |
| Angiodynamics, INC. | $22.74 | 2021 | |
| Cardiva Medical, INC. | $20.78 | 2024 | Optowire |
| Lundbeck LLC | $16.52 | 2019 | |
| Cook Medical LLC | $14.34 | 2022 | |
| Daiichi Sankyo INC. | $14.13 | 2021 | |
| Medtronic, INC. | $14.08 | 2021 | |
| Chiesi USA, INC. | $11.98 | 2019 | |
| Sanofi-Aventis U.S. LLC | $11.95 | 2019 | |
| Esperion Therapeutics, INC. | $11.82 | 2021 | |
| Tactile Systems Technology INC | $11.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Eckert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.